MiCare Path just pulled off a move that feels less like a funding round and more like a plot twist the industry should have seen coming but somehow didn’t. Their 4th round lands quietly on paper, yet the impact hits like a bassline at 3 a.m., especially paired with the acquisition of Compwell. When a company expands its virtual care footprint and simultaneously absorbs a care management group, you know the strategy isn’t improvisation. It is orchestration.
Scott Laster has been shaping this trajectory since 2019 with 18 years of global med device and digital health leadership behind him. When someone has launched 4 platform systems, managed integrations topping $300M, authored peer-reviewed work, and stacked patents like it is a casual Tuesday, you expect intention. MiCare Path moves with the kind of precision that comes from actually understanding the grind clinicians face rather than pitching from the cheap seats.
Brian Childress brings 30+ years of commercial firepower from corporations generating $6B+ combined revenue. He has lived every angle of healthcare sales, from independent rep to sales director to distributor, building nearly $300M in business along the way. His record of top-tier national performance explains why MiCare Path’s customer success and sales engine feels more like a seasoned operator than a young platform finding its footing. He knows what clinics adopt, what they reject, and what they secretly wish existed.
Corey Patrick rounds out the trio with a global background across orthopedics, wound care, sports medicine, ENT, and digital health on 4 continents. Engineering, health economics, compliance, risk, and CMS negotiations all sit in his toolkit. When someone has worked with top hospitals across the US and Canada and helped increase reimbursement amounts, it shows in the product. Operational rigor isn’t just a priority for MiCare Path. It is a reflex.
Growth has been loud even if the company refuses to brag about it. Tens of thousands of patients across 12 specialties. A team of 40+ nationwide. FDA registered software built for RPM, RTM, CCM, PCM, and AWV workflows. By mid 2024 they had collected 102M+ data points and worked with 5,200+ physicians across 21 states. Partnerships with AdventHealth, ASOP, and the Memphis Medical Society reinforce that this platform isn’t playing in the shallow end.
The Compwell acquisition levels up the entire equation. Care management and virtual assessment capabilities now plug directly into a system already engineered for national scale. MiCare Path isn’t pretending to guide patients between visits. They are building the infrastructure that makes it possible. And for clinics and health systems trying to deliver specialty care without losing the thread, that kind of clarity is rare.
Startups Startup Funding Venture Capital Healthcare Health Tech Virtual Care Digital Health Compliance Data Data Driven Infrastructure Technology Innovation Tech Ecosystem Startup Ecosystem
